Skip to main content

Iressa Expanded Access Program (EAP)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Iressa Expanded Access Program (EAP)

Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Iobenguane I-131 or Crizotinib and Standard Therapy in Treating Younger Patients With Newly-Diagnosed High-Risk Neuroblastoma or Ganglioneuroblastoma

MEMO-Medical Marijuana and Opioids Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about MEMO-Medical Marijuana and Opioids Study

Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Minimizing Toxicity in HLA-identical Related Donor Transplantation for Children With Sickle Cell Disease

Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy

Study Evaluating Subjects With Distal Renal Tubular Acidosis

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study Evaluating Subjects With Distal Renal Tubular Acidosis

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 220
  • Page 221
  • Page 222
  • Page 223
  • Page 224
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • …
  • Next page Next
  • Last page Last
Subscribe to